Follow
T cell infiltration tumor
T cells are a type of immune cell involved in identifying and killing cancer cells. T cells that infiltrate tumors, known as tumor infiltrating T cells (TILs), are a positive prognostic factor for cancer patients. Cellular therapies remove TILs from a patient, expand them in a laboratory, and administer them back to the patient.
-
FEB 29, 2024Immunology
Myeloid cells are a population of cells classified to denote a specific lineage. “Myeloid” specifically refe ...Written By: Brian G. MorrealeFEB 22, 2024Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as ...Written By: Brian G. MorrealeFEB 15, 2024Immunology
Scientists have dedicated their lives to finding a cure for cancer. America became a science hub for cancer research, pa ...Written By: Brian G. MorrealeDEC 25, 2023Cancer
Regulatory T cells, Tregs for short, represent a divisive type of immune cell that can elicit beneficial but also harmfu ...Written By: Katie KokolusNOV 30, 2023Immunology
Engineered immune cells have been the topic of investigation for the last few decades. Just 11 years ago a child was tre ...Written By: Brian G. MorrealeSEP 08, 2023Drug Discovery & Development
Groundbreaking clinical trial that unveils the power of neoadjuvant anti-PD-1 therapy in head and neck squamous cell car ...Written By: Amielle MorenoAUG 16, 2023Immunology
Glioblastoma is a fast-growing and aggressive brain tumor. As one of the most common malignant brain tumors, life expect ...Written By: Brian G. MorrealeMAY 09, 2023Immunology
Cancer immunotherapy constantly evolves, and discoveries and treatments targeting more aggressive cancers are published ...Written By: Brian G. MorrealeAPR 17, 2023Immunology
Bacteria can live in a lot of unusual places, even in tumors in the human body. Scientists have now taken advantage of t ...Written By: Carmen LeitchOCT 28, 2022Cancer
Pancreatic ductal adenocarcinoma (PDAC), a highly aggressive type of pancreatic cancer, has a very poor prognosis due, a ...Written By: Katie KokolusOCT 18, 2022Immunology
Introduction The immune system plays a dual role in inflammation and cancer development. Immune system effector cells ra ...Sponsored By: Sino BiologicalOCT 13, 2022Cell & Molecular Biology
Cancer is basically what happens when cells start growing and dividing uncontrollably, and it gets worse when those canc ...Written By: Carmen LeitchSEP 26, 2022Cancer
One type of cancer immunotherapy, called oncolytic viral therapy, works by infecting cancer cells with a specific virus. ...Written By: Katie KokolusJUN 09, 2022Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive pancreatic cancer with limited treatment options. PDA ...Written By: Katie KokolusMAY 09, 2022Cancer
Following a successful course of cancer treatment, a patient may enter remission. Remission, classified as either partia ...Written By: Katie KokolusAPR 20, 2022Cancer
Recent advances in immune checkpoint inhibitors (ICI) have led to significant clinical benefits for patients with variou ...Written By: Katie KokolusDEC 02, 2021Cancer
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, accounting for about 90% of pancre ...Written By: Katie KokolusOCT 04, 2021Cancer
IsoPlexis’ Single-Cell Proteomics Predict Progression-Free Survival in Melanoma Study While advancements in oncolo ...Sponsored By: IsoPlexis LeMAY 31, 2021Immunology
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...Written By: Tara FernandesMAR 22, 2021Immunology
Immunologists have identified a mechanism through which an oncogene mutation shields pancreatic tumors from immune cells ...Written By: Tara FernandesMAR 02, 2021Immunology
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...Written By: Tara FernandesFEB 04, 2021Cancer
A team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a microchip system that models immune ...Written By: Kathryn DeMuth SullivanJAN 30, 2021Cancer
New research published in Advanced Science from scientists at the University of Michigan Rogel Cancer Center and U- ...Written By: Kathryn DeMuth SullivanOCT 08, 2020Immunology
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...Sponsored By: Human Metabolome Technologies
FEB 29, 2024
Immunology
Myeloid cells are a population of cells classified to denote a specific lineage. “Myeloid” specifically refe
...
Written By:
Brian G. Morreale
FEB 22, 2024
Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as
...
Written By:
Brian G. Morreale
FEB 15, 2024
Immunology
Scientists have dedicated their lives to finding a cure for cancer. America became a science hub for cancer research, pa
...
Written By:
Brian G. Morreale
DEC 25, 2023
Cancer
Regulatory T cells, Tregs for short, represent a divisive type of immune cell that can elicit beneficial but also harmfu
...
Written By:
Katie Kokolus
NOV 30, 2023
Immunology
Engineered immune cells have been the topic of investigation for the last few decades. Just 11 years ago a child was tre
...
Written By:
Brian G. Morreale
SEP 08, 2023
Drug Discovery & Development
Groundbreaking clinical trial that unveils the power of neoadjuvant anti-PD-1 therapy in head and neck squamous cell car
...
Written By:
Amielle Moreno
AUG 16, 2023
Immunology
Glioblastoma is a fast-growing and aggressive brain tumor. As one of the most common malignant brain tumors, life expect
...
Written By:
Brian G. Morreale
MAY 09, 2023
Immunology
Cancer immunotherapy constantly evolves, and discoveries and treatments targeting more aggressive cancers are published
...
Written By:
Brian G. Morreale
APR 17, 2023
Immunology
Bacteria can live in a lot of unusual places, even in tumors in the human body. Scientists have now taken advantage of t
...
Written By:
Carmen Leitch
OCT 28, 2022
Cancer
Pancreatic ductal adenocarcinoma (PDAC), a highly aggressive type of pancreatic cancer, has a very poor prognosis due, a
...
Written By:
Katie Kokolus
OCT 18, 2022
Immunology
Introduction The immune system plays a dual role in inflammation and cancer development. Immune system effector cells ra
...
Sponsored By:
Sino Biological
OCT 13, 2022
Cell & Molecular Biology
Cancer is basically what happens when cells start growing and dividing uncontrollably, and it gets worse when those canc
...
Written By:
Carmen Leitch
SEP 26, 2022
Cancer
One type of cancer immunotherapy, called oncolytic viral therapy, works by infecting cancer cells with a specific virus.
...
Written By:
Katie Kokolus
JUN 09, 2022
Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive pancreatic cancer with limited treatment options. PDA
...
Written By:
Katie Kokolus
MAY 09, 2022
Cancer
Following a successful course of cancer treatment, a patient may enter remission. Remission, classified as either partia
...
Written By:
Katie Kokolus
APR 20, 2022
Cancer
Recent advances in immune checkpoint inhibitors (ICI) have led to significant clinical benefits for patients with variou
...
Written By:
Katie Kokolus
DEC 02, 2021
Cancer
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, accounting for about 90% of pancre
...
Written By:
Katie Kokolus
OCT 04, 2021
Cancer
IsoPlexis’ Single-Cell Proteomics Predict Progression-Free Survival in Melanoma Study While advancements in oncolo
...
Sponsored By:
IsoPlexis Le
MAY 31, 2021
Immunology
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors.
...
Written By:
Tara Fernandes
MAR 22, 2021
Immunology
Immunologists have identified a mechanism through which an oncogene mutation shields pancreatic tumors from immune cells
...
Written By:
Tara Fernandes
MAR 02, 2021
Immunology
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat
...
Written By:
Tara Fernandes
FEB 04, 2021
Cancer
A team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a microchip system that models immune
...
Written By:
Kathryn DeMuth Sullivan
JAN 30, 2021
Cancer
New research published in Advanced Science from scientists at the University of Michigan Rogel Cancer Center and U-
...
Written By:
Kathryn DeMuth Sullivan
OCT 08, 2020
Immunology
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re
...
Sponsored By:
Human Metabolome Technologies